Dalit agitation death toll mounts

Agencies
April 3, 2018

New Delhi/Bhopal/Lucknow/Jaipir, Apr 3 : At least seven people were killed and many injured in violence on Monday as Dalit protesters went on a rampage during a nationwide bandh against the dilution of the SC/ST (Prevention of Atrocities) Act.

While five people were killed in cross-firing in Madhya Pradesh alone, one each died in Uttar Pradesh and Rajasthan, according to officials there.

Curfew was imposed in several places and hundreds were detained.

Fifteen companies or 1,700 personnel of Rapid Action Force were rushed to UP, MP and Rajasthan. Two companies of the BSF were sent to Punjab.

Transport, mobile and internet services were hit in many states with over 100 trains getting affected due to protests.

Some states had ordered closure of educational institutions as a precaution.

Incidents of arson, firing and vandalism were reported from many states.

Appealing for peace, Union Home Minister Rajnath Singh said the government was committed to ensuring the welfare of Scheduled Castes and Scheduled Tribes and guaranteeing them full protection of law. "I am deeply pained by the acts of violence and loss of precious lives in some parts of the country," he said.

In Madhya Pradesh, two died in Gwalior, two in Bhind and one in Morena.

Sources said that one person was killed in Muzaffarnagar in UP, when pro-bandh supporters opened fire while forcing closure of shops. Another person received bullet injuries and was admitted to the hospital, where his condition was stated to be critical.

Police detained nearly 400 people, including former BSP MLA from Meerut Yogesh Verma .

UP Chief Minister Yogi Adityanath appealed for peace and urged the people not to vitiate law and order.

The CBSE has already postponed Class 12 and Class 10 examinations scheduled to be held on Monday in Punjab at the request of the state government.

The Supreme Court had on March 20 diluted certain provisions of the Scheduled Caste and Scheduled Tribe (Prevention of Atrocities) Act, in a bid to protect 'honest' public servants discharging bona fide duties from being blackmailed with false cases under the Act.

Western UP districts having sizable Dalit population witnessed large scale violence.

Dozens of vehicles were torched in Muzaffarnagar, Meerut. They also attacked scribes and molested women, sources said.

BSP supremo Mayawati attributed the violence to ''outside criminal elements'' and asked the government to identify such people and punish them.

In Rajasthan, Pawan Kumar, a youth, died in police firing after protesters attacked a police station in Alwar and tried to set it ablaze. "A youth sucummbed to injuries. He along with other protestors had beaten up the police and were trying to burn the police station," N R K Reddy (ADG Law & Order) confirmed.

Meanwhile Rajasthan Chief Minister Vasundhara Raje appealed for peace in the state.

In Punjab, the Indo-Pak bus service too was hit. The Lahore-bound bus from Delhi was made to go off the road at Sirhind, while the Delhi-bound bus from Lahore was stopped at Amritsar.

In Gujarat, though there have been no reports of any loss of life or major incidents of violence, crowds stopped vehicules on highways and in the cities and got into scuffles with the police.

Comments

shaji
 - 
Tuesday, 3 Apr 2018

This shows utter failure of Central Govt.  Looting, arson, unrest, killing of innocents, destruction of publice + Govt properties etc is going on all over India and Central Govt is unable to control it.  The only thing it doing is rise in fuel prices to bring profit to business tycoons.  Govt should step down immedaitely taking moral responsibilities of death of scrores of innocents.  Goondas and Terrorists of sangh parivar are taking law in their own hand and POlice is silently watching it. Its really shame.  Its as if Police is supporting these terrorists. If this continues, i think economy of India will go down.  President should interfere and take necessary action.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 24,2020

Kozhikode, Apr 24: A four-month-old baby girl, who had tested positive for COVID-19 and suffering from congenital heart disease, died in a hospital here in Kerala early Friday after suffering a cardiac arrest, officials said.

This is the third COVID-19 death and the first infant fatality in the state where two elderly people had succumbed to the disease earlier.

The baby was admitted to the Medical College Hospital here on April 21 with history of fever, cough, breathing difficulties and seizure after being treated at two other hospitals and the end came at 6 am, a medical bulletin said.

State Health Minister K K Shailaja said doctors had made maximum efforts to save the life of the child, whose family belonged to Payyanad near Manjeri in Malappuram district.

"Preliminary information which we have is that there has been some primary contact", she told reporters in Thiruvananthapuram.

The protocol for COVID-19 cases would be followed for the baby's last rites, the Minister added.

As of Thursday, the total active COVID-19 cases in the state stood at 129.

The bulletin said on arrival at the hospital on Tuesday the baby was in shock and had respiratory failure.

"She was resuscitated, mechanically ventilated and appropriate antibiotics for pneumonia and supportive measures to correct shock were started", it said adding the baby, however, continued to remain sick.

"Even though there was no history of any high or low risk contact or any epidemiological links as the child comes from SARI (Sever Acute Respiratory infection) criteria, she was admitted to the COVID-ICU and swab was taken and she tested positive", the bulletin said.

Contact tracing of those who had come in contact with the child was in progress.

Mallapuram District Medical Officer (Health) Dr Sakeena K said the child was having severe health issues from its birth itself and was admitted to a private hospital in Manjeri near here with breathing problem.

As her condition worsened, the baby was shifted to another hospital and later to the medical college hospital.

"The baby was having chest deformity and Atrial Septal Defect by birth which developed into severe health issues, the official added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 28,2020

New Delhi, May 28: BJP national spokesperson Sambit Patra has been admitted to a private hospital in Gurgaon after he showed symptoms of COVID-19, sources said.

He is admitted to the Medanta hospital in Gurgaon, hospital sources said on Thursday.

The BJP leader has shown symptoms of COVID-19, a source said.

Patra is one of the most visible BJP faces on news channels.

He is also very active on social media and posted several tweets on Thursday as well.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.